Back to Market Feed

KERENDIA 40 MG TABLET

finerenone
$22.8604per EA

Strength

40 mg/1

NDC

50419054202

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

FINERENONE

Approval Type

New Drug (NDA)

FDA Application

NDA215341

On Market Since

7/9/2021

Pharmacological Classes

Mineralocorticoid Receptor Antagonists
Nonsteroidal Mineralocorticoid-Receptor Antagonist

Price History

1W

0.0%

1M

0.0%

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

N/A

Generic Alternatives

1 alternative • Same active ingredient

KERENDIA 40 MG TABLET
Brand
50419054201•Bayer HealthCare Pharmaceuticals Inc.
$22.8604

Related Drugs

Same classification

No related drugs found.